Moderna’s Strategic Shift: From COVID-19 Vaccine Leader to mRNA Pipeline Diversification Moderna, Inc. (NASDAQ: MRNA) is currently recalibrating its business model as the global demand for COVID-19 vaccines stabilizes. Following …
Tag:
Moderna
-
-
News
Moderna launches Phase 3 trial of mRNA bird flu vaccine in UK and US to protect high-risk groups
Moderna has begun a Phase 3 trial of its mRNA-based bird flu vaccine in the UK and US, enrolling approximately 4,000 participants to test protection against the A(H5N1) strain. The …
-
FDA to Offer Bonuses to Drug Reviewers Amid Staffing Concerns and Push for Faster Approvals WASHINGTON (AP) — The Food and Drug Administration (FDA) plans to implement a pilot program …
-
FDA Reverses Course, Will Review Moderna’s mRNA Flu Vaccine The U.S. Food and Drug Administration (FDA) will now review Moderna’s novel, messenger RNA (mRNA)-based flu vaccine after reversing its initial …
-
Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren …
-
“`html Governors Urge Congress to Increase Federal Medicaid Funding Governors Call on Congress to Bolster Federal Medicaid Funding Table of Contents Governors Call on Congress to Bolster Federal Medicaid Funding …